A Short-Term Cost-of-Treatment Model for Type 2 Diabetes: Comparison of Glipizide Gastrointestinal Therapeutic System, Metformin, and Acarbose
Joe W. Ramsdell, MD, Joseph A. Grossman, MD, Jennifer M. Stevens, PharmD, Marc F. Botteman, MSc, MA, Raul Arocho, PhDThe American Journal of Managed Care, August 1999, Volume 5, Issue 8